Interpace Biosciences Inc (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,814 | -33,560 | -34,461 | -9,974 | 11,809 |
| Depreciation Amortization | 1,829 | 2,838 | 4,613 | 5,607 | 5,764 |
| Income taxes - deferred | 5 | -1,443 | 331 | 1,113 | 2,710 |
| Accounts receivable | 2,095 | 3,928 | 6,965 | 2,680 | 2,460 |
| Accounts payable and accrued liabilities | 522 | -304 | -494 | -1,123 | -1,778 |
| Other Working Capital | 19,070 | -5,964 | 11,948 | -5,361 | -2,552 |
| Other Operating Activity | -355 | 18,533 | -4,893 | 882 | 1,272 |
| Operating Cash Flow | $16,352 | $-15,972 | $-15,991 | $-6,176 | $19,685 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,130 | -1,730 | -399 | -1,009 | -1,770 |
| Net Acquisitions | -23,912 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -5,546 | -15,050 | -35,990 | -93,801 |
| Sale Of Investment | N/A | 5,700 | 22,391 | 97,450 | 29,920 |
| Other Investing Activity | 0 | 0 | 0 | 150 | 250 |
| Investing Cash Flow | $-26,042 | $-1,576 | $6,942 | $60,601 | $-65,401 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 87 |
| Other Financing Activity | -62 | -63 | -62 | -461 | 23 |
| Financing Cash Flow | $-62 | $-63 | $-62 | $-461 | $110 |
| Beginning Cash Position | 72,463 | 90,074 | 99,185 | 45,221 | 90,827 |
| End Cash Position | 62,711 | 72,463 | 90,074 | 99,185 | 45,221 |
| Net Cash Flow | $-9,752 | $-17,611 | $-9,111 | $53,964 | $-45,606 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,352 | -15,972 | -15,991 | -6,176 | 19,685 |
| Capital Expenditure | -2,130 | -1,730 | -399 | -1,009 | -1,770 |
| Free Cash Flow | 14,222 | -17,702 | -16,390 | -7,185 | 17,915 |